| Date |
Title |
Rating |
| 2009-11-30 |
GLUMETZA patent infringement lawsuit against Lupin |
None |
| 2009-11-30 |
Pharmacists could play important role in reform |
None |
| 2009-11-30 |
BioMarin Pharmaceutical receives FDA orphan drug designation for 3,4-DAP |
None |
| 2009-11-30 |
Xencor licenses its XmAb and Xtend technology platforms to Centocor Research & Development |
None |
| 2009-11-30 |
Bavarian Nordic to file a NDS for IMVAMUNE with Health Canada |
None |
| 2009-11-30 |
Allos Therapeutics granted U.S. patent for FOLOTYN |
None |
| 2009-11-30 |
Eli Lilly's Cymbalta receives FDA approval |
None |
| 2009-11-30 |
Cell Therapeutics' platinum-based anti-tumor compounds demonstrate stronger anti-tumor potency |
None |
| 2009-11-30 |
CCAC congratulates the Ontario government for expanding access to Avastin |
None |
| 2009-11-30 |
Detailed new report on generic pharmaceuticals market in Japan |
None |
| 2009-11-30 |
Comprehensive report on South East Asian pharmaceutical market |
5 |
| 2009-11-28 |
PanGenex expects release of television program on Calci-CLEAR dietary supplement |
None |
| 2009-11-28 |
Report on the US intranasal drug delivery market |
None |
| 2009-11-28 |
Latin American pharmaceutical market to grow up to $51.3bn in 2014 |
5 |
| 2009-11-28 |
EMEA determines MAA for omacetaxine mepesuccinate for treatment of CML patients |
None |
| 2009-11-28 |
Cromoz's new drug delivery system to reduce amount of drugs used in cancer treatment |
None |
| 2009-11-28 |
Detailed report on anxiety drug pipeline from Research and Markets |
None |
| 2009-11-27 |
Agriflu approved to prevent diseases caused by influenza virus subtypes A and B |
None |
| 2009-11-27 |
Rights Issue to be carried out by keeping the authorization by the Annual General Meeting, resolves Tripep |
None |
| 2009-11-27 |
Comprehensive review on pain management pharmaceuticals market |
None |
| 2009-11-27 |
Stallergenes granted European approval to market Oralair |
None |
| 2009-11-27 |
Parkinson disease drug pipeline report from Research and Markets |
None |
| 2009-11-27 |
European Commission approves MICARDIS medication for CV protection |
None |
| 2009-11-27 |
Detailed report on Alzheimer disease drug pipeline |
None |
| 2009-11-27 |
Varicose veins drug pipeline report from Research and Markets |
None |
| 2009-11-27 |
Health Canada announces recent changes made to heparin manufacturing standards |
None |
| 2009-11-27 |
Report on global osteoporosis therapeutics market |
None |
| 2009-11-27 |
NCKU, ScinoPharm Taiwan sign MOU to establish university-industry cooperation |
None |
| 2009-11-27 |
Copper sequestering drug tetrathiomolybdate shown to be effective in treating Wilson disease |
None |
| 2009-11-27 |
Risk of postnatal transmission can be reduced with HAART in HIV-positive mothers |
None |
| 2009-11-27 |
Complete analysis of pharmaceutical industry in Norway |
None |
| 2009-11-26 |
ALDA Pharmaceuticals and Shoppers Drug Mart sign distribution agreement |
None |
| 2009-11-26 |
MICARDIS receives Health Canada approval to reduce the risk of non-fatal stroke |
None |
| 2009-11-26 |
Comparative analysis of Central and Eastern European policies towards generic and innovative drug applications |
None |
| 2009-11-26 |
OSEO awards fund for Galapagos NV's antibody therapeutics program |
None |
| 2009-11-26 |
Cipla Medpro receives 2009 Frost & Sullivan South Africa Company of the Year Award in the Generic Pharmaceutical Market |
None |
| 2009-11-26 |
Prescriptions for cholestrol therapy filled after the release of Arbiter 6-HALTS study results |
None |
| 2009-11-26 |
MUHC's innovative treatment for HIV patients passes first clinical trial successfully |
5 |
| 2009-11-26 |
Merck, Idera Pharmaceuticals extend their vaccine research collaboration |
None |
| 2009-11-26 |
Report on pain management pharmaceuticals market |
None |
| 2009-11-26 |
Complete review of thrombosis drug pipeline |
None |
| 2009-11-26 |
Comprehensive report on the global market for regenerative medicine |
None |
| 2009-11-26 |
New article discusses the balance between pain management and drug safety |
None |
| 2009-11-26 |
Dermatologists express strong interest in Stelara, despite concerns |
None |
| 2009-11-25 |
Patients may not benefit from e-samples of prescription drugs, says UW |
5 |
| 2009-11-25 |
Erbitux drug can reverse rare stomach disorder, report researchers |
None |
| 2009-11-25 |
Tibotec Therapeutics' INTELENCE granted FDA traditional approval |
None |
| 2009-11-25 |
Lethality of H1N1 virus has dropped from its peak of 3.7, shows new data |
None |
| 2009-11-25 |
No evidence of improved survival for epinephrine administered patients during ACLS |
5 |
| 2009-11-25 |
Data miners can inform drug companies of doctors' prescribing habits |
None |
| 2009-11-25 |
Sinovac Dalian JV to research, develop, produce and commercialize human-use vaccines |
None |
| 2009-11-25 |
QLT announces litigation settlement with Massachusetts General Hospital |
None |
| 2009-11-25 |
Human Genome Sciences submits BLA for ZALBIN |
None |
| 2009-11-25 |
FDA approves Berinert for treating HAE in adults and adolescents |
None |
| 2009-11-25 |
Report on CXCR agonists and CXCR/CXCL antagonists |
None |
| 2009-11-25 |
In-depth review of restenosis drug pipeline |
None |
| 2009-11-25 |
Emerging markets, key players and future trends in the CMO market |
None |
| 2009-11-25 |
Pennsylvanians at-risk for H1N1 flu receive H1N1 vaccination |
None |
| 2009-11-25 |
NIPTE to develop educational programs on leading edge pharmaceutical technology for FDA reviewers |
None |
| 2009-11-25 |
2010 promises to continue acquisition activity as companies seek ways to bolster their pipelines and portfolios |
5 |
| 2009-11-25 |
Emerging cancer vaccines: Forecasts, new developments and pipeline analysis |
None |
| 2009-11-25 |
Pharmaceutical research and biotechnology companies test medicines and vaccines to treat HIV/AIDS |
None |
| 2009-11-25 |
Competitive Intelligence Report about Hsp90 inhibitors |
None |
| 2009-11-25 |
Incyte enters into collaboration and license agreement with Novartis |
None |
| 2009-11-25 |
Initiation of Phase II clinical trial to evaluate the efficacy of BN83495 announced |
None |
| 2009-11-25 |
Multiple presentations from clinical and preclinical studies of ISTODAX to be presented |
None |
| 2009-11-25 |
Eisai's NDA for Aricept tablets for treatment of Alzheimer's disease accepted for review |
1 |
| 2009-11-25 |
Comprehensive report on stroke, cardiovascular and circulatory system drug pipelines |
1 |
| 2009-11-25 |
New findings suggest current system of classifying psychoactive drugs in UK may need to be revisited |
2 |
| 2009-11-25 |
Worldwide collaboration leads to treatment for rare skin disorder |
None |
| 2009-11-24 |
Several new vaccines require booster shots to remain effective during a lifetime: Study |
None |
| 2009-11-24 |
Shanghai Biolaxy receives IND approval for insulin formulation to treat diabetes |
None |
| 2009-11-24 |
Reboxetine drug does not alleviate depression, says new study |
None |
| 2009-11-24 |
Africa region leaders meet to discuss H1N1 procurement, distribution |
None |
| 2009-11-24 |
Gilead Sciences and GSK to commercialize Viread in 5 Asian countries |
5 |
| 2009-11-24 |
Medical Nutrition launches Diff-Stat pre- and probiotic supplement to prevent the onset of AAD and C-diff |
2.5 |
| 2009-11-24 |
Shire submits a MAA for velaglucerase alfa in Europe |
None |
| 2009-11-24 |
Report on the pipeline status of peripheral vascular disease drugs |
None |
| 2009-11-24 |
Pharmacy-based intervention improves antipsychotic adherence among patients with mental illnesses |
None |
| 2009-11-24 |
Cardiovascular risks associated with taking Vioxx could have been identified earlier, say researchers |
None |
| 2009-11-24 |
NCCN Guidelines adds ofatumumab and romidepsin as therapy options for CLL |
None |
| 2009-11-24 |
Report on the arrhythmiasis drug pipeline |
None |
| 2009-11-24 |
Transcept Pharmaceuticals to discuss the Complete Response Letter for Intermezzo NDA |
None |
| 2009-11-24 |
New data indicates early association between anti-inflammatory medication and cardiovascular risk |
None |
| 2009-11-24 |
U.S. Court rules in Merck's favor in Flemings case involving FOSAMAX |
None |
| 2009-11-24 |
Older adults who take psychotropic medications more likely to experience falls |
None |
| 2009-11-24 |
Clavis Pharma signs drug development and commercialisation agreement with Clovis Oncology |
None |
| 2009-11-24 |
Iowa State University's researcher develops and ships H1N1 vaccine for swine producers |
None |
| 2009-11-24 |
Clavis Pharma announces $380 million agreement to develop its CP-4126 drug candidate |
None |
| 2009-11-24 |
New technology developed to rapidly identify compounds for the treatment of heart failure |
None |
| 2009-11-24 |
Breast cancer patients treated with chemotherapy drug Taxol more likely to develop chronic neuropathic pain |
None |
| 2009-11-24 |
Lysteda tablets to treat menorrhagia approved by the FDA |
1 |
| 2009-11-24 |
Treatment rates for hepatitis C virus declining, say researchers |
None |
| 2009-11-24 |
PX’Therapeutics sets up additional biomanufacturing unit |
None |
| 2009-11-24 |
Neuromed discusses Exalgo NDA application with the FDA |
None |
| 2009-11-24 |
DTCA linked with increased Medicaid pharmacy expenditures |
None |
| 2009-11-24 |
Jubilant Organosys, UAB and Southern Research Institute announce joint venture to accelerate global drug development |
None |
| 2009-11-24 |
AmKor and Hengdian Group sign license agreement to develop and market new drug candidate in China |
None |
| 2009-11-24 |
10 x '20 Initiative calls for global commitment to develop 10 new antibiotics by 2020 |
4 |
| 2009-11-23 |
AP/News-Observer examines state of vaccine research |
None |
| 2009-11-23 |
Alleged HIPAA violations by CVS Caremark, again |
5 |
| 2009-11-23 |
BioTrends Research Group releases Wave 2 report on AMAG's Feraheme |
None |
| 2009-11-23 |
Walgreens re-launches its website with expanded shopping tools and services |
None |
| 2009-11-23 |
Caldolor Injection effective in treating fever in hospitalized burn patients |
None |
| 2009-11-23 |
FDA grants Fast Track designation for ARCA biopharma's Gencaro |
None |
| 2009-11-23 |
Texas Court dismisses all claims against Merck in VIOXX-related lawsuit |
None |
| 2009-11-23 |
Isis Pharmaceuticals CEO's letter to shareholders |
None |
| 2009-11-23 |
Librax AG version launched by Oceanside Pharmaceuticals |
3.5 |
| 2009-11-23 |
NAPRELAN Dose Card launched by Victory Pharma |
None |
| 2009-11-23 |
New FluCide better than the older version |
None |
| 2009-11-23 |
Spectrum Pharmaceuticals, Handok Pharmaceuticals sign collaboration agreement |
None |
| 2009-11-23 |
New Drug Application for ticagrelor submitted to the FDA |
None |
| 2009-11-23 |
Third-quarter news report on pharmaceutical market access, pricing, and reimbursement |
None |
| 2009-11-21 |
Review of study presented at American Heart Association Scientific Sessions |
None |
| 2009-11-21 |
Multi-state electronic tracking program to prevent diversion of common medicines for methamphetamine production |
None |
| 2009-11-21 |
Pennsylvania Department of Health commences H1N1 vaccination to members of priority groups |
None |
| 2009-11-21 |
Carvedilol in combination with ACE inhibitors may benefit cardiac patients |
None |
| 2009-11-21 |
Chemical-based tooth whitening or bleaching agents may be harmful, ADA warns |
None |
| 2009-11-21 |
Zoladex consumers entitled to treble damages, Court rules |
None |
| 2009-11-21 |
FDA approves Pfizer's Geodon Capsules for the adjunctive maintenance treatment of bipolar disorder |
5 |
| 2009-11-21 |
Employers take action to improve medication adherence |
None |
| 2009-11-20 |
FDA approves sNDA for pediatric autism drug ABILIFY |
5 |
| 2009-11-20 |
FDA Warning Letter for Deconsal: Cornerstone Therapeutics preparing a response |
None |
| 2009-11-20 |
Evidence does not connect H1N1 vaccine to patient deaths, WHO says |
None |
| 2009-11-20 |
Antibiotic resistance a growing problem, particularly in southern, eastern Europe |
None |
| 2009-11-20 |
News outlets examine malaria drug resistance, hope for malaria eradication in Africa |
None |
| 2009-11-20 |
"Hotline" report on finasteride for prevention of prostate cancer |
None |
| 2009-11-20 |
Antigenics to withdraw its MAA for Oncophage following CHMP’s negative opinion |
None |
| 2009-11-20 |
FDA acknowledges Dendreon's amended BLA for PROVENGE as a complete response |
None |
| 2009-11-20 |
Pfizer’s Revatio Injection receives FDA approval |
None |
| 2009-11-20 |
FDA extends Exalgo NDA review by three months |
5 |
| 2009-11-20 |
Quest Diagnostics reports sharp downward trends in cocaine and methamphetamine use |
None |
| 2009-11-20 |
Soligenix receives $9.4M NIAID grant to develop technology for advancing rapidly acting vaccines |
None |
| 2009-11-20 |
Inovio Biomedical announces positive test results of its consensus influenza vaccines |
1 |
| 2009-11-20 |
Comprehensive coverage of generic drugs market in the United States |
None |
| 2009-11-20 |
BioForm Medical and Galderma Laboratories Chiefs to offer their perspectives on aesthetics market at ODAC conference |
None |
| 2009-11-20 |
Issues affecting the U.S., European and Japanese pharmaceutical industry |
None |
| 2009-11-20 |
Global market for anti-depressants on a decline |
None |
| 2009-11-20 |
Review of R&D and novel therapeutic challenges in neurological disorders |
None |
| 2009-11-20 |
Only 1 in 4 Americans aged 50-64 regularly take advantage of preventive screenings, says report |
None |
| 2009-11-20 |
Study examines temporal association between media coverage and opioid-related deaths |
None |
| 2009-11-20 |
LAIV and TIV vaccines appear to offer protection against A/H1N1 virus |
None |
| 2009-11-20 |
Deloitte Consulting offers new sales strategy for pharmaceutical companies |
None |
| 2009-11-20 |
Report on the global market trends in pharmaceutical contract manufacturing |
None |
| 2009-11-20 |
Global initiative battles online supply of dangerous and illegal medicines |
None |
| 2009-11-20 |
Significant increases in IT use have not reduced drug review process |
None |
| 2009-11-20 |
Health technology assessment to influence coverage of neurology drugs in most markets |
None |
| 2009-11-20 |
Health care reform will not impact America's pharmaceutical research industry |
None |
| 2009-11-20 |
Discoveries on anti-HIV antibodies may help researchers create an effective HIV vaccine |
None |
| 2009-11-20 |
US and European market for radiopharmaceuticals continues to gain momentum |
None |
| 2009-11-20 |
Elsevier journal Vaccine releases a supplement dedicated to vaccines for biodefense |
None |
| 2009-11-20 |
Purchasing prescription drugs in a three-month supply reduce cost of drugs for patients |
None |
| 2009-11-20 |
Scientists find how 4-HB is metabolized by the body |
None |
| 2009-11-20 |
Hepatitis C Virus therapeutics development landscape continues to inflate |
None |
| 2009-11-20 |
ScinoPharm receives Potent Compound Safety Certification from SafeBridge Consultants |
None |
| 2009-11-20 |
Swissmedic grants marketing authorization for Amitiza |
None |
| 2009-11-20 |
New market research report on Australia's pharmaceuticals and healthcare industry |
None |
| 2009-11-20 |
Kenya pharmaceuticals and healthcare report from Research and Markets |
None |
| 2009-11-20 |
Experimental drug to restore function of nerves damaged in spinal cord injuries shows promise |
None |
| 2009-11-19 |
CDAS, Prestwick Chemical sign drug discovery research agreement |
None |
| 2009-11-19 |
Ligon Discovery raises $1 million |
None |
| 2009-11-19 |
Pfizer,DNDi partner to Identify NTD drugs; Sanofi-Aventis, medicines for malaria launch drug study |
None |
| 2009-11-19 |
Op-Eds: HIV travel ban; improving sanitation; counterfeit drugs |
None |
| 2009-11-19 |
MONITORING FORCE files for Flibanserin orphan drug status designation with the EMEA |
None |
| 2009-11-19 |
VisEn Medical launches two new agents for imaging quantification |
None |
| 2009-11-19 |
ScinoPharm Taiwan receives the SafeBridge Potent Compound Safety Certification |
None |
| 2009-11-19 |
Astellas Pharma and XenoPort submit NDA in Japan for PMDA approval |
None |
| 2009-11-19 |
Updated clinical guidelines on Effient treatment for ACS patients |
1 |
| 2009-11-19 |
NPSF supports obligatory flu vaccination for healthcare workers |
None |
| 2009-11-19 |
Findings suggest athletes abuse non-approved therapeutic compounds for performance enhancing effects |
None |
| 2009-11-19 |
USP releases new CRMs for carbamazepine, phenytoin, and theophylline |
None |
| 2009-11-19 |
Study: EP4 agonist may reduce gastric bleeding and inflammation |
None |
| 2009-11-19 |
FDA Advisory Committee votes in support of Pfizer's Prevnar 13 |
None |
| 2009-11-19 |
FDA: Plavix-Prilosec combination may reduce anti-clotting effect |
None |
| 2009-11-19 |
Data from Phase 1 safety study of SB-728-T announced |
None |
| 2009-11-19 |
FDA issues complete response for Rituxan, a drug for treating chronic lymphocytic leukemia |
None |
| 2009-11-19 |
New radical approach to test chemo drugs for potential toxic effects |
None |
| 2009-11-19 |
Halifax researcher wins Prix Galien Research Award |
None |
| 2009-11-19 |
Pfizer and DNDi to battle against HAT, VL and Chagas disease |
None |
| 2009-11-19 |
Xeomin receives approval for post-stroke spasticity of upper limb in European countries |
None |
| 2009-11-19 |
Opiate-based painkillers can increase tumor-cell proliferation, says new study |
5 |
| 2009-11-19 |
Sildenafil drug improves cardiac performance in young adults with congenital heart disease |
None |
| 2009-11-19 |
People with egg allergy can have H1N1 flu vaccine in graded doses |
None |
| 2009-11-19 |
Experimental study shows beneficial effects of Vardenafil on NSAID-induced gastric ulcer |
None |
| 2009-11-19 |
Results from Phase IIa clinical trial evaluating VT-111 reported by Viron Therapeutics |
None |
| 2009-11-19 |
Dual niacin-statin therapy improves blood cholesterol levels but does not diminish plaque buildup |
None |
| 2009-11-19 |
Once-a-day dosing clinical study of udenafil for erectile dysfunction completed |
5 |
| 2009-11-19 |
WHO to launch yellow fever vaccination campaign in West Africa |
None |
| 2009-11-19 |
Humana to commence 'Limited Income Newly Eligible Transition' program for CMS |
None |
| 2009-11-19 |
Interim data from an ongoing phase 1 dose-escalation trial of XL147 reported |
None |
| 2009-11-19 |
New non-alcohol germ protection spray now available in Greater Cleveland |
None |
| 2009-11-19 |
GAVI Alliance drives down pentavalent vaccine costs, data shows |
None |
| 2009-11-19 |
Nicardipine Hydrochloride Injection for short-term treatment of hypertension launched |
None |
| 2009-11-18 |
Tips for lessening needle anxiety |
5 |
| 2009-11-18 |
U.S. health officials testify before Senate Committee about H1N1 vaccine campaign |
None |
| 2009-11-18 |
Generic and brand-name drug makers face off |
None |
| 2009-11-18 |
New data on Synta Pharmaceuticals' elesclomol presented at the AACR-NCI-EORTC Conference |
None |
| 2009-11-18 |
New pre-clinical data from Alnylam Pharmaceuticals' ALN-VSP program presented |
None |
| 2009-11-18 |
Pfizer Canada accepts Prix Galien Canada 2009 Innovative Product Award for CHAMPIX |
None |
| 2009-11-18 |
Insights into evolving pharmacovigilance trends and their impact on biosimilars and generic products |
None |
| 2009-11-18 |
Sinovac Biotech receives a revised production license for its Panflu.1 vaccine |
None |
| 2009-11-18 |
Positive results from REVIVE, a phase 3 pivotal study of avanafil announced |
None |
| 2009-11-18 |
Study: Larger dose of ARBs is more effective in heart failure patients |
None |
| 2009-11-18 |
Report on ophthalmic pharmaceutical drugs market |
None |
| 2009-11-18 |
Drug interaction between clopidogrel and omeprazole: New safety information |
1.5 |
| 2009-11-18 |
KAI Pharmaceuticals to receive manufacturing services from Formatech |
None |
| 2009-11-18 |
Pentavalent price drops: the GAVI effect |
None |
| 2009-11-18 |
Competitive intelligence on Bahrain's pharmaceuticals and healthcare industry |
None |
| 2009-11-18 |
Request for pre-IND meeting to discuss IND application for therapeutic vaccine granted by FDA |
None |
| 2009-11-18 |
Ambrisentan improves health and exercise capacity of PAH patients, find researchers |
None |
| 2009-11-18 |
CRESTOR reduces major cardiovascular events in women by 46% |
1 |
| 2009-11-18 |
Pediatric data for Pfizer's Lipitor submitted to the EMEA |
None |
| 2009-11-18 |
Data demonstrate that danger of low levels of HDL is not reduced by statin treatment |
5 |
| 2009-11-18 |
Drug market for acute ischemic stroke to reach $450M in 2018 |
None |
| 2009-11-18 |
New study reveals certain prescription drugs can be harmful to fetus |
None |
| 2009-11-18 |
New Drug Application for NicOx's naproxcinod accepted for filing |
None |
| 2009-11-18 |
On-going Phase 2b study conducted by Roche of ITMN-191 modified |
None |
| 2009-11-18 |
Pre-clinical data of GM1485 to be presented by GliaMed |
None |
| 2009-11-18 |
Study examines link between folic acid and cancer incidence |
None |
| 2009-11-18 |
New research report on world gelatin industry |
4 |
| 2009-11-18 |
Study to test anti-tumor effects of AEOL 10150 initiated |
None |
| 2009-11-18 |
Sildenafil improves heart function in youngsters with single ventricle congenital heart disease |
None |
| 2009-11-18 |
CTSA institutions receive NIH grants to study drug safety and efficacy in children |
None |
| 2009-11-18 |
Tel Aviv University develops new wound dressing packed with infection-fighting antibiotics |
5 |
| 2009-11-18 |
Ongoing Phase 1 study results of XMT-1001 announced by Mersana Therapeutics |
None |
| 2009-11-18 |
FDA approves Qutenza, a pain relief product for patients who suffer from PHN |
None |
| 2009-11-18 |
SIRO Clinpharm and Mediscis team up to expand clinical development plans |
None |
| 2009-11-17 |
China, WHO to collaborate on flu research center |
None |
| 2009-11-17 |
Abbott and BG Medicine announce a development and commercialization agreement for galectin-3 biomarker |
None |
| 2009-11-17 |
Cancer pain drug market to be $3.7 billion in 2018 |
None |
| 2009-11-17 |
Bavarian Nordic awarded a new contract for developing a freeze-dried version of its IMVAMUNE smallpox vaccine |
None |
| 2009-11-17 |
Bayer's NEXAVAR approved in over 70 countries for the treatment of liver cancer |
None |
| 2009-11-17 |
Scientists solve 50-year-old thalidomide puzzle |
None |
| 2009-11-17 |
Total of 1,686,100 doses of H1N1 vaccine allocated to Pennsylvania to date: Department of Health |
None |
| 2009-11-17 |
Opportunities and challenges in the psychiatric disease market |
None |
| 2009-11-17 |
AACR-NCI-EORTC conference highlights major expansion in cancer drug pipeline |
None |
| 2009-11-17 |
Comprehensive report on UK vitamins and supplements industry |
None |
| 2009-11-17 |
New, reversible antiplatelet drug not superior than irreversible one in patients undergoing PCI |
None |
| 2009-11-17 |
Shire publishes new study results on INTUNIV Extended-Release Tablets |
None |
| 2009-11-17 |
LEAD Therapeutics discovers orally available PARP inhibitor |
None |
| 2009-11-17 |
Genzyme receives FDA complete response letter for its Lumizyme marketing application |
None |
| 2009-11-17 |
Genentech submits sBLAs to the FDA for Avastin |
None |
| 2009-11-17 |
FDA provides feedback on the pending NDA for EXALGO tablets |
None |
| 2009-11-17 |
BioSante Pharmaceuticals applauds Boehringer Ingelheim for developing a therapy to treat HSDD |
None |
| 2009-11-17 |
Comprehensive report on Mexican pharmaceutical market |
None |
| 2009-11-17 |
Antidepressant drug is effective in treating women with low libido |
None |
| 2009-11-17 |
FDA approves NeurogesX's Qutenza patch for postherpetic neuralgia treatment |
5 |
| 2009-11-17 |
FDA approves Par Pharmaceutical's new painkiller drug |
None |
| 2009-11-17 |
Statin therapy should still be used first to reach blood cholesterol levels before considering niacin |
None |
| 2009-11-17 |
ARCA biopharma provides financial and Gencaro NDA update |
None |
| 2009-11-17 |
FDA approves CSL's seasonal and H1N1 flu vaccines for children |
4 |
| 2009-11-17 |
Researchers attempt to slow the pace of infectious organisms' evolution to keep today's drugs effective |
None |
| 2009-11-17 |
Complete analysis of pharmaceutical industry in Belgium |
5 |
| 2009-11-17 |
Handwashing: A simple, effective way to prevent the spread of communicable diseases |
None |
| 2009-11-17 |
Reorganizing the FDA could save Americans trillions of dollars over the next decade, says legal expert |
None |
| 2009-11-16 |
Additional vaccine for 2009 H1N1 flu approved by FDA |
None |
| 2009-11-16 |
ECR Pharmaceuticals to commercialize and manufacture ZolpiMist in the U.S. and Canada |
4 |
| 2009-11-16 |
Report on Venezuela's pharmaceuticals and healthcare industry |
None |
| 2009-11-16 |
Eisai's LUSEDRA Injection now available for MAC sedation |
None |
| 2009-11-16 |
Decision Resources: Neuropathic pain drug market to be $9.7B in 2018 |
None |
| 2009-11-16 |
4SC raises funds for further development of its current product pipeline |
None |
| 2009-11-16 |
Drug makers hike prices, lobby hard as reform efforts progress |
None |
| 2009-11-16 |
Onyx Pharmaceuticals acquires Proteolix |
None |
| 2009-11-16 |
Gentium to present Defibrotide trial data at the ASH meeting |
None |
| 2009-11-16 |
Erbitux recognized as one of the major clinical cancer advances of 2009 |
None |
| 2009-11-16 |
FDA approves Lysteda for treating menorrhagia |
None |
| 2009-11-16 |
Windhover Information selects Oncothyreon's PX-866 among top 10 oncology projects for partnering |
None |
| 2009-11-16 |
Sinobiopharma's 23 generic drugs on China's National Essential Drugs List |
None |
| 2009-11-16 |
FDA issues a Complete Response Letter for Human Genome Sciences' raxibacumab BLA |
None |
| 2009-11-16 |
Genta announces Phase 3 trial results of Genasense |
None |
| 2009-11-16 |
Macomb County targets pregnant women and health care workers for its next two H1N1 vaccine clinics |
None |
| 2009-11-16 |
Inovio Biomedical reports financial results for the three and nine months ended September 30, 2009 |
None |
| 2009-11-16 |
Foreign particles in some products filled at Genzyme's Allston Landing facility, "Dear Doctor" letter issued |
None |
| 2009-11-16 |
Ketamine use increasing faster than any other drug in the UK, shows research |
4 |
| 2009-11-16 |
Effect of niacin or ezetimibe added to chronic statin therapy on carotid intima media thickness: Study |
None |
| 2009-11-16 |
Proteo's Elafin recommended for orphan drug status in Europe |
None |
| 2009-11-16 |
Normal synaptic activity in nerve cells protects brain from Huntington's disease |
None |
| 2009-11-16 |
Research and Markets' report on analyzing the Indian pharmaceutical industry |
None |
| 2009-11-16 |
Potential of the European Biomarker Analysis Market to be the focus at upcoming Analyst Briefing |
None |
| 2009-11-16 |
Some combination drug therapies are counter-productive |
None |
| 2009-11-16 |
Department of Health to conduct statewide clinics to administer free H1N1 vaccine |
None |
| 2009-11-16 |
New reversible oral anti-platelet medication had fewer cardiac events in heart attack patients |
None |
| 2009-11-16 |
Chronic pain patients with depression three times more likely to receive opioid medications |
None |
| 2009-11-16 |
TIME examines efforts to combat malaria resistance along Thai-Cambodia border |
None |
| 2009-11-16 |
Merck to market and develop cardiovascular medicines for a range of cardiovascular disorders |
None |
| 2009-11-16 |
Phase I clinical study for ETC-1002 commenced |
None |
| 2009-11-15 |
Priority Review of the NDA for intravenous acetaminophen extended by three months |
None |
| 2009-11-13 |
Report on the outlook for pharmaceuticals in Central & Eastern Europe to 2013 |
None |
| 2009-11-13 |
Current status report on kidney stones medications |
5 |
| 2009-11-13 |
New research report on Deoxyarbutin market |
None |
| 2009-11-13 |
$1.2 million federal grant to University of Illinois for botanical dietary supplements research |
None |
| 2009-11-13 |
New market research report on inflammation drugs |
None |
| 2009-11-13 |
Reportlinker releases new market research report on Diclofenac sodium |
None |
| 2009-11-13 |
Medicare Part D program exceeds expectations, majority of seniors approve their plan and coverage |
5 |
| 2009-11-13 |
Pharmacyclics to present clinical updates and posters relating to PCI-24781 and PCI-32765 |
None |
| 2009-11-13 |
Axelar AB to present data from ongoing Phase I/II clinical trial of AXL1717 |
1 |
| 2009-11-13 |
Report on the export of Chinese chemical active pharmaceutical ingredients from 2004 to 2009 |
None |
| 2009-11-13 |
Insight into the pipeline status of atherosclerosis or coronary artery disease drugs |
None |
| 2009-11-13 |
New market research report on Butylresorcinol |
None |
| 2009-11-13 |
Shire announces findings from Phase 3 study data with Vyvanse |
None |
| 2009-11-13 |
Reportlinker releases new market research report on influenza drugs |
None |
| 2009-11-13 |
New market research report on Asia-Pacific pharma sector |
None |
| 2009-11-13 |
Idaho's U.S. Representatives oppose HR 3962: AARP disappointed |
None |
| 2009-11-13 |
New market research report on osteoarthritis drugs |
None |
| 2009-11-13 |
Comprehensive report on Asian pharmaceutical market |
None |
| 2009-11-13 |
Health Canada approves ONGLYZA for type 2 diabetes treatment |
4 |
| 2009-11-13 |
Vanderbilt University researchers study role of statins in reducing flu-related deaths |
None |
| 2009-11-13 |
Report on the key drivers in the Netherland pharmaceutical market |
None |
| 2009-11-13 |
An overview of the global Cinmethylin market |
None |
| 2009-11-13 |
CSL's H1N1 influenza vaccine receives approval from FDA for use in children ages 6 months and older |
None |
| 2009-11-13 |
Nutra Pharma to market its OTC pain reliever in Brazil and Colombia, begins the drug registration process |
None |
| 2009-11-13 |
Report on skin infection medications |
None |
| 2009-11-13 |
Research and Markets' extensive and objective analysis on the Asia-Pacific pharma market |
None |
| 2009-11-13 |
Abbott signs agreement to acquire global rights to PanGenetics BV's PG110 |
None |
| 2009-11-13 |
New and effective medicines underway for treating a wide range of diseases affecting women |
None |
| 2009-11-13 |
Report on digestive system ulcers drug pipeline |
None |
| 2009-11-13 |
Key drivers in Lithuania's pharmaceutical market |
None |
| 2009-11-13 |
Reportlinker releases detailed report on HSV infection drugs |
None |
| 2009-11-13 |
New market research report on colon cancer drugs |
None |
| 2009-11-13 |
Intervention to reduce over-dispensing of asthma medications effective without compromising patient safety |
None |
| 2009-11-13 |
Ipsen receives marketing authorization in France for its 6-month sustained-release formulation of Decapeptyl |
None |
| 2009-11-13 |
Bioniche Pharma acquires injectable drugs from Xanodyne Pharmaceuticals |
None |
| 2009-11-12 |
CDC expected to revise estimated number of U.S. H1N1 deaths |
None |
| 2009-11-12 |
Overview of latest news and developments status of pain medications |
None |
| 2009-11-12 |
Cequent Pharmaceuticals proposes the first test of an orally administered RNA interference drug in humans |
None |
| 2009-11-12 |
Spectrum Pharmaceuticals reports consolidated revenues of $7.1M for the third quarter of 2009 |
None |
| 2009-11-12 |
MAP Pharmaceuticals to sell up to $60 million of its registered common stock to Azimuth Opportunity |
None |
| 2009-11-12 |
Review of Mersana Therapeutics's lead compound, XMT-1001 to be published |
None |
| 2009-11-12 |
Baby Boomers seek alternatives for prescription only treatments for menopause symptoms |
None |
| 2009-11-12 |
A discreet option for pain relief in the workplace |
None |
| 2009-11-12 |
ORC Guideline's recent research on the impact of social media and pharmaceutical marketing |
None |
| 2009-11-12 |
Stelara expected to change dermatologists’ prescribing habits and alter patient flow models |
None |
| 2009-11-12 |
IACC to include vaccine research studies in the objectives of the updated Strategic Plan for Autism Research |
None |
| 2009-11-12 |
Creation and implemention of a market development plan for protein kinase drug in oncology |
None |
| 2009-11-12 |
Future trends and developments in the global generics market |
None |
| 2009-11-12 |
Canadian researchers organize clinical trials to find new treatments for H1N1 infection |
None |
| 2009-11-12 |
PIKAMAB announces the development of ADCC Therasight, a novel theragnostic product |
None |
| 2009-11-12 |
In-depth analysis of South and Central American API market |
None |
| 2009-11-12 |
Investors are betting on upcoming medical study results of BioElectronics, says BioMedReports |
None |
| 2009-11-12 |
Updated efficacy results from Allos Therapeutics' FOLOTYN study to be presented at the ASH meeting |
None |
| 2009-11-12 |
FDA approves CSL Biotherapies' seasonal flu vaccine, Afluria for children |
None |
| 2009-11-12 |
54% of Americans are inconsistent in taking prescriptions, reveals survey |
None |
| 2009-11-12 |
Nuvo Research announces new licensing agreement for Oxoferin |
None |
| 2009-11-12 |
Report on Australian antidiabetics market |
None |
| 2009-11-12 |
Comprehensive report on CRC market |
None |
| 2009-11-12 |
Some benefits from prescription drug DTCA, but significant risks remain |
None |
| 2009-11-12 |
FDA regulatory clearance for Kensey Nash's ECM product |
None |
| 2009-11-12 |
CVS Caremark's medication adherence program for people with diabetes has positive impact |
None |
| 2009-11-12 |
Drug companies collaborate with nonprofit organizations to fight "neglected" diseases in the developing world |
None |
| 2009-11-11 |
CVS settles with NY over expired product sales; NC gets high-risk pool payment help |
None |
| 2009-11-11 |
Research and Markets' Competitive Intelligence Report on TGF-R agonists and antagonists |
None |
| 2009-11-11 |
FDA accepts Sol-Gel’s Investigational New Drug Application for DER45-EV Gel |
None |
| 2009-11-11 |
Engineers develop technology to ensure "right first time" drug crystal formation in existing chemical reactors |
None |
| 2009-11-11 |
Dental Dental Pain report offers update on dental pain drugs pipeline |
None |
| 2009-11-11 |
In-depth information of the American, European and Japanese pharmaceutical markets |
None |
| 2009-11-11 |
AMA's Prescribing Data Restriction Program |
None |
| 2009-11-11 |
Reportlinker's new market research report on M-Xylylenediamine |
None |
| 2009-11-11 |
New report on metabolic endocrinology hypocalcemia drug pipeline |
None |
| 2009-11-11 |
Cholesterol-lowering drugs associated with reduced risk of gallstone disease |
None |
| 2009-11-11 |
Duke University, Jubilant Organosys sign letter of intent for drug development partnership |
None |
| 2009-11-11 |
UIC receives federal grant to develop new antibiotics against anthrax, tularemia and plague |
None |
| 2009-11-11 |
Report on the global market for pain therapeutics |
None |
| 2009-11-11 |
Reportlinker releases new market research report on ear infections drugs |
None |
| 2009-11-11 |
Overview of the current global market for neurodegenerative drugs |
5 |
| 2009-11-11 |
Potential benefits of Labopharm's novel trazodone formulation published |
None |
| 2009-11-11 |
FDA Commissioner thanks America's doctors for their efforts during 2009 H1N1 influenza outbreak |
None |
| 2009-11-11 |
Research trends in the global drug delivery market |
None |
| 2009-11-11 |
Insight into the pipeline status of non-hodgkin lymphoma drugs |
None |
| 2009-11-11 |
Update on pipeline status of hyperlipemia drugs |
None |
| 2009-11-11 |
Sanofi-aventis, Regeneron sign agreement to expand development collaboration |
None |
| 2009-11-11 |
Pipeline status of myocardial infarction drugs: Report |
None |
| 2009-11-11 |
Capecitabine in chemotherapy regimen reduces early breast cancer recurrence |
None |
| 2009-11-11 |
Report on the emerging market for cancer vaccines |
None |
| 2009-11-11 |
Lower socioeconomic status linked with inability to fight H1N1 |
3 |
| 2009-11-11 |
Onyx Pharmaceuticals to present data on carfilzomib and ONX 0803 at the 51st ASH Annual Meeting |
None |
| 2009-11-11 |
New market research report on insomnia drugs |
None |
| 2009-11-11 |
Particle Sciences expands operations by acquiring new additional space |
None |
| 2009-11-11 |
Acute coronary syndromes drug report from Research and Markets |
None |
| 2009-11-11 |
Allos Therapeutics awards NCCN a grant to evaluate pralatrexate |
None |
| 2009-11-11 |
New HPV vaccine eliminates chronic infection and reduces precancerous genital lesions in women |
5 |
| 2009-11-11 |
New market research report on throat infection drugs |
None |
| 2009-11-11 |
Insight into the gastroesophageal reflux disease drug pipeline |
None |
| 2009-11-11 |
Mylan subsidiary receives FDA approval for its Lansoprazole DR Capsules ANDA |
None |
| 2009-11-11 |
Sprycel holds hope for treating Src dependent ovarian cancer |
None |
| 2009-11-11 |
Key players in the Brazilian pharmaceutical industry |
None |
| 2009-11-11 |
Westaim executes amalgamation agreement with NUCRYST Pharmaceuticals |
None |
| 2009-11-11 |
Data on Alexion Pharmaceuticals' Soliris to be presented at the ASH meeting |
2 |
| 2009-11-11 |
Anemia-reducing medications linked to deep vein thrombosis in cancer patients |
None |
| 2009-11-11 |
Roxane Laboratories receives ANDA approval for Perindopril Erbumine Tablets |
None |
| 2009-11-11 |
Microbix Biosystems receives Health Canada's marketing and export approval for KINLYTIC |
None |
| 2009-11-11 |
Comprehensive report on macular degeneration drugs and disease specific pipeline projects |
None |
| 2009-11-10 |
Teva Pharmaceutical's generic lansoprazole does not infringe patent No. 5,464,632: U.S. Court |
None |
| 2009-11-10 |
Cerimon Pharmaceuticals acquires rights to develop and commercialize diclofenac sodium patch in Europe |
None |
| 2009-11-10 |
U.S. DOD grant to study vigabatrin in combination with opiates to manage pain |
None |
| 2009-11-10 |
GSK to donate 50M H1N1 vaccine doses to WHO in coming months |
None |
| 2009-11-10 |
Levulan PDT may reduce the rate of recurrence of SCCs in solid organ transplant recipients: Study |
None |
| 2009-11-10 |
HHS Secretary to visit Bradenton Healthcare Center to discuss the importance of H1N1 vaccinations |
5 |
| 2009-11-10 |
Despite economic slowdown, Central and Eastern European countries still represent an attractive healthcare market |
None |
| 2009-11-10 |
NIH awards $6.8 million subcontract to Kineta to develop vaccine immune boosters |
None |
| 2009-11-10 |
Key drivers in the Israeli pharmaceutical market |
None |
| 2009-11-10 |
Atherosclerosis drug pipeline report from Research and Markets |
None |
| 2009-11-10 |
Teva Pharmaceutical Industries amends patent infringement lawsuit against Momenta Pharmaceuticals/Sandoz |
None |
| 2009-11-10 |
Cannabinoid medicine: Challenges for health care providers and its potential benefits for patients |
None |
| 2009-11-10 |
H1N1 vaccine updates from Pennsylvania Department of Health |
None |
| 2009-11-10 |
Astellas receives exclusive rights to develop and commercialize linaclotide compound in Asia |
None |
| 2009-11-10 |
Novartis to acquire 85% stake in Zhejiang Tianyuan Bio-Pharmaceutical for US$125 million |
None |
| 2009-11-10 |
MicroDose Therapeutx acquires potential compounds for treatment of respiratory syncytial virus |
None |
| 2009-11-10 |
Global Health Initiative launched by The Association of University Technology Managers |
None |
| 2009-11-10 |
Flu-Ease provides flu shots at airports |
None |
| 2009-11-10 |
FDA approves Istodax for treatment of Cutaneous T-cell Lymphoma |
None |
| 2009-11-10 |
European Union funds a three-year project to establish a research network for complementary medicine study |
None |
| 2009-11-10 |
FDA accepts ChemGenex Pharmaceuticals' NDA for Omapro |
None |
| 2009-11-10 |
Diabetic Care Services responds to NRF's updated “Buyer Beware” list |
None |
| 2009-11-09 |
TRICARE South Region beneficiaries urged to get H1N1 influenza vaccinations |
None |
| 2009-11-09 |
VaxInnate licensed to use 3M Drug Delivery Systems' TLR agonists |
None |
| 2009-11-09 |
AAFP's initiative to raise awareness about whooping cough vaccination for adolescents and adults |
None |
| 2009-11-09 |
Scientific article supports AEterna Zentaris' development of perifosine inhibitor |
None |
| 2009-11-09 |
Global Health Ventures completes prototype manufacturing of its "X-Excite" male enhancement drug |
None |
| 2009-11-09 |
Shire's INTUNIV for treating ADHD now available in the U.S. |
None |
| 2009-11-09 |
Covidien contraindicates use of its Optimark gadoversetamide injection |
5 |
| 2009-11-09 |
Enzon Announces to sell its specialty pharmaceutical business to the sigma-tau Group for $300 million |
None |
| 2009-11-09 |
Ikano Therapeutics' midazolam granted Orphan Drug designation |
None |
| 2009-11-09 |
CRINONE vaginal progesterone gel as effective as IM progesterone for luteal phase support in IVF-ET |
None |
| 2009-11-09 |
Decision Resources forecasts sales of HER2-targeting agents to grow by 3.3% per year |
None |
| 2009-11-09 |
Report on the pharmaceutical market in Morocco |
None |
| 2009-11-09 |
Simcere Pharmaceutical Group signs agreement to acquire manufacturing license from Tianjin Tianda Pharmaceutical |
None |
| 2009-11-09 |
SuperGen to stage presentations to review clinical and non-clinical advances in different compounds |
None |
| 2009-11-09 |
Bend Research signs collaboration agreement with Vertex Pharmaceuticals |
None |
| 2009-11-09 |
Puredel's Ossulin consistently delivers about 20% of the insulin dose |
None |
| 2009-11-09 |
Analysis of the leading companies in the South African pharmaceutical industry |
None |
| 2009-11-09 |
Daval International receives award for its anti-inflammatory agent AIMSPRO |
4.5 |
| 2009-11-09 |
Health Canada accepts for review the EpiCept’s New Drug Submission for Ceplene |
5 |
| 2009-11-07 |
Betterthanmedicare.com helps plug the "donut hole", offers discounts on drugs |
5 |
| 2009-11-07 |
Transatlantic task force to address antibiotic resistance established, experts welcome initiative |
None |
| 2009-11-07 |
Competitive intelligence report on Portugal's pharmaceuticals and healthcare industry |
None |
| 2009-11-07 |
Locus Pharmaceuticals creates a new division, Ansaris |
None |
| 2009-11-07 |
Biopharma companies need to incorporate innovative elements in their business models to survive healthcare reform |
None |
| 2009-11-07 |
FDA extends review date of New Drug Application for GSK1838262/XP13512 |
None |
| 2009-11-07 |
Lithuania's OTC pharmaceutical market to reach a value of LTL2.13bn by 2013 |
None |
| 2009-11-07 |
Report provides critical strategic insight for companies with a stake in the market for rheumatology therapies |
None |
| 2009-11-07 |
Experts applaud the EU Presidency for establishing a transatlantic task force to address antibiotic resistance |
None |
| 2009-11-07 |
Comprehensive report on Brazilian pharmaceutical market |
None |
| 2009-11-07 |
Key drivers in Argentine pharmaceutical market |
None |
| 2009-11-07 |
World outlook for anti-obesity drugs across more than 2000 cities |
None |
| 2009-11-07 |
Peru pharmaceuticals and healthcare report from Research and Markets |
None |
| 2009-11-07 |
Poll examines the American public's response to H1N1 vaccine shortage |
None |
| 2009-11-07 |
Rituximab drug potentially effective for treating Graves' eye disease, shows study |
5 |
| 2009-11-07 |
Report on the US pharmaceuticals and healthcare markets |
None |
| 2009-11-06 |
Calbiotech awarded a SBIR contract to develop analyte specific reagents for the diagnosis of Dengue virus |
None |
| 2009-11-06 |
Swine flu vaccine distribution to New York companies causes uproar |
None |
| 2009-11-06 |
Gonorrhea medication may help fight cancer |
None |
| 2009-11-06 |
CVS investigated by FTC over business practices |
None |
| 2009-11-06 |
55% of adult population in Greater Washington, DC say they will not get H1N1 flu vaccine, reveals poll results |
None |
| 2009-11-06 |
H1N1 is now most dominant flu strain worldwide, WHO says |
None |
| 2009-11-06 |
ART as part of HIV prevention strategy supported by WHO |
None |
| 2009-11-06 |
Report on the South African pharmaceuticals and healthcare industry |
None |
| 2009-11-06 |
"No Drugs Down the Drain" outreach campaign in Sacramento |
None |
| 2009-11-06 |
CREW urge HHS to investigate CDC's approval to distribute H1NI vaccine to Wall Street firms |
None |
| 2009-11-06 |
Eggs sensitivity and flu shot: Doctors' dilemma |
None |
| 2009-11-06 |
Pharmacists are necessary to the medical care model |
None |
| 2009-11-06 |
Journal of Infectious Diseases' special edition on rotavirus |
None |
| 2009-11-06 |
CPEX Pharmaceuticals to feature Nasulin at the Diabetes Technology Meeting |
None |
| 2009-11-06 |
Grant awarded for research into a new treatment for methamphetamine addiction |
None |
| 2009-11-06 |
Wedgewood Pharmacy announces compounding of thyroid tablets in response to physician demand |
None |
| 2009-11-06 |
Citracal Calcium plus Heart Health helps support bone and heart health in women |
None |
| 2009-11-06 |
Physicians concern about the spread of H1N1 virus and the availability of H1N1 vaccine |
None |
| 2009-11-06 |
In-depth report on the pharmaceutical market in Japan |
None |
| 2009-11-06 |
Patent covering the approved administration of Kuvan with food issued |
None |
| 2009-11-06 |
TREANDA induces durable responses in indolent B-cell non-Hodgkin's lymphoma patients |
None |
| 2009-11-06 |
FDA grants orphan drug designation for Sunesis Pharmaceuticals' voreloxin |
3.5 |
| 2009-11-06 |
Bipolar disorder drug market to decline from $6.3 billion to $5 billion |
None |
| 2009-11-06 |
Quintiles opens expanded regional headquarters facility in Singapore |
None |
| 2009-11-06 |
ImmunoLin provides immediate benefit to the function of immune system and gut |
None |
| 2009-11-06 |
Wide gap between perceived and real determinants of antibiotic prescription exists, says researcher |
None |
| 2009-11-06 |
Pfizer extends JAK3 research collaboration with Ligand Pharmaceuticals |
None |
| 2009-11-06 |
USPTO issues Notice of Allowance to NovaDel Pharma |
None |
| 2009-11-06 |
Medtipster announces new promotion to help Michigan residents save on their prescription costs |
None |
| 2009-11-06 |
Unum enhances the wellness benefit of its critical illness products by adding H1N1 vaccine |
None |
| 2009-11-06 |
DSM Pharmaceutical Products announces manufacturing alliance with Galenix |
None |
| 2009-11-06 |
New FDA program targets drug dosage errors |
None |
| 2009-11-06 |
Walls Street journal examines big pharma's 'growing interest' in emerging-market vaccine development, production |
None |
| 2009-11-06 |
DOJ investigates alleged fraud by drugmakers; sanctions on wellcare lifted |
None |
| 2009-11-06 |
FDA: Sexual enhancement product "Stiff Nights" can dangerously lower blood pressure and is illegal |
None |
| 2009-11-06 |
HHS announces contract awards for up to 120,000 treatment courses of intravenous antiviral drugs |
None |
| 2009-11-06 |
Prescription drug abuse among teens: NCPIE, SAMHSA launches campaign |
None |
| 2009-11-05 |
Bortezomib lymphoma drug may be effective against bone cancer in children and teens: Study |
None |
| 2009-11-05 |
GenVec and SAIC-Frederick signs contract to develop influenza and HIV vaccines |
None |
| 2009-11-05 |
Consumers in search of saving money should reconsider prescription drug choices |
None |
| 2009-11-05 |
Catalent Pharma Solutions, Endotis Pharma forge alliance to develop oral formulations of small-glycol drugs |
None |
| 2009-11-05 |
Althea Technologies offers formulation development services |
None |
| 2009-11-05 |
U.S. health officials offer no prediction of when all high-risk groups will have access to H1N1 vaccine |
None |
| 2009-11-05 |
FDA grants Abraxis BioScience orphan drug designation for ABRAXANE |
None |
| 2009-11-05 |
FDA approves the New Drug Application for Pennsaid Topical Solution |
None |
| 2009-11-05 |
Atrium Medical presents final results of its "COCTAIL study" |
None |
| 2009-11-05 |
Pennsaid Topical Solution approved by FDA |
None |
| 2009-11-05 |
Study finds oral dimercaptosuccinic acid effective in treating children with autism |
5 |
| 2009-11-05 |
Prenatal DHA, a product developed for pregnant women to ensure adequate DHA, introduced |
None |
| 2009-11-05 |
Can American ginseng relieve health problems? |
None |
| 2009-11-05 |
Mandatory minimum sentences for drug-related offences, an ineffective approach |
None |
| 2009-11-05 |
Patients with post-traumatic stress disorder can benefit from synthetic marijuana |
5 |
| 2009-11-05 |
CHANTIX/CHAMPIX raises hope for quitting smoking |
None |
| 2009-11-05 |
InterMune seeks FDA marketing approval for pirfenidone |
5 |
| 2009-11-05 |
NIAID funds CCHI and IMVC programs to help identify new vaccines for emerging infectious diseases |
None |
| 2009-11-05 |
USPTO awards Peregrine Pharmaceuticals patent for anti-viral uses of phosphatidylserine targeting antibodies |
None |
| 2009-11-05 |
Micro-injector may help rapid development of new generation of drugs |
None |
| 2009-11-05 |
Pfizer and Flamel Technologies sign license agreement |
None |
| 2009-11-05 |
Nano-size capsule that boosts the body's uptake of curcumin being developed |
2 |
| 2009-11-04 |
Department of Health urges healthcare professionals to be vaccinated against H1N1 flu |
None |
| 2009-11-04 |
Also in Global Health News: Childhood vaccines; USAID administrator; Pakistan polio fight; UNICEF fundraising; measles in India |
None |
| 2009-11-04 |
News outlets examine international efforts to contain H1N1 |
None |
| 2009-11-04 |
Statins may have negative effects on some cardiac patients, says study |
None |
| 2009-11-04 |
AMFm subsidized malaria drugs to be delivered soon |
None |
| 2009-11-04 |
GenVec receives FDA orphan drug designation for TNFerade |
None |
| 2009-11-04 |
Gastric cancer drug market to double to nearly $1.5 billion in 2018 |
None |
| 2009-11-04 |
PAH patients face life-threatening risks from medication errors |
3 |
| 2009-11-04 |
Poland’s pharmaceutical industry report from Research and Markets |
None |
| 2009-11-04 |
GSK's malaria vaccine trial containing Antigenics’ Stimulon adjuvant enrolls more than 5,000 children |
None |
| 2009-11-04 |
Shionogi files New Drug Application in Japan |
None |
| 2009-11-04 |
New report on Russia's pharmaceutical industry |
None |
| 2009-11-04 |
USPTO issues Notice of Allowance for Transcept Pharmaceuticals' Intermezzo |
None |
| 2009-11-04 |
ResearchPoint celebrates 10th anniversary |
None |
| 2009-11-04 |
TNF-alpha inhibitors ranked top for reducing biologics spend |
None |
| 2009-11-04 |
Cost of ADHD clinical trials can be reduced by implementing Quotient ADHD System |
None |
| 2009-11-04 |
Report on the global anti-infectives market |
None |
| 2009-11-04 |
International Omega-3 Awareness Day to educate public about proven health benefits of omega-3 |
None |
| 2009-11-04 |
Scientists develop technique to predict new target diseases for existing drugs |
None |
| 2009-11-04 |
Study results of nucleoside polymerase and protease inhibitor combination therapy for HCV promising |
5 |
| 2009-11-04 |
Takeda Pharmaceuticals strengthens its North American market |
None |
| 2009-11-04 |
Survey shows majority of rheumatologists would prescribe Actemra drug for rheumatoid arthritis |
None |
| 2009-11-04 |
Key players in the Italian pharmaceutical industry |
None |
| 2009-11-04 |
Canadian patients have less access to the latest medicines, says report |
5 |
| 2009-11-04 |
Predictive Biosciences commences clinical trials of its bladder cancer assay |
None |
| 2009-11-04 |
MagForce Nanotechnologies completes clinical trial of Nano-Cancer therapy in glioblastoma patients |
None |
| 2009-11-04 |
Report: Pandemic flu threat influences vaccine market to expand rapidly |
None |
| 2009-11-04 |
Teva Pharmaceutical launches Fexofenadine HCl and Pseudoephedrine HCl tablets |
None |
| 2009-11-04 |
H1N1 vaccine: Discussions and debates |
None |
| 2009-11-04 |
U.S. clinical trials show single dose of H1N1 vaccine protects pregnant women, children under 10 need two doses |
None |
| 2009-11-04 |
Department of Health: CDC has allocated 964,100 doses of H1N1 vaccine to Pennsylvania to date |
None |
| 2009-11-04 |
Common pain killers may blunt the effect of flu shots |
None |
| 2009-11-04 |
Lovastatin-synthesizing enzyme successfully reconstituted |
None |
| 2009-11-03 |
EntreMed to present its Aurora A/angiogenic kinase inhibitor data at the AACR-NCI-EORTC conference |
None |
| 2009-11-03 |
Report on the Russian pharmaceutical market |
None |
| 2009-11-03 |
Acorda Therapeutics' financial results for the third quarter of 2009 and update on Fampridine-SR |
None |
| 2009-11-03 |
Schering-Plough to donate $200,000 and vaccine for rabies-control projects in India |
None |
| 2009-11-03 |
AMRI receives $750,000 milestone payment from Bristol-Myers Squibb |
None |
| 2009-11-03 |
Macomb County Health Department announces H1N1 influenza clinic |
None |
| 2009-11-03 |
Prasco Laboratories to provide distribution services for generic versions of Allegra-D and Drisdol |
None |
| 2009-11-03 |
Tamiflu in short supply, pharmacists compound doses for children suffering from the H1N1 flu virus |
None |
| 2009-11-03 |
Crohn's disease drug market driven by TNF-alpha inhibitors Humira and Remicade |
None |
| 2009-11-03 |
Efficacy trial of the world's most clinically advanced malaria vaccine candidate underway |
None |
| 2009-11-03 |
FDA update on BYETTA injection: Amylin Pharmaceuticals and Eli Lilly respond |
None |
| 2009-11-03 |
New drug may help bone fractures heal more quickly after radiation exposure |
3 |
| 2009-11-03 |
FDA updates Byetta prescribing information following reports of kidney problems |
5 |
| 2009-11-03 |
Pregnant women tolerate the 2009 H1N1 flu vaccine, mount strong immune response |
None |
| 2009-11-03 |
Cipher Pharmaceuticals to defend alleged patent infringement of CIP-TRAMADOL ER |
None |
| 2009-11-03 |
Top-line results from Phase 3 linaclotide trial for chronic constipation |
None |
| 2009-11-03 |
Cardium Therapeutics to seek FDA marketing clearance for ExcellagenXL |
None |
| 2009-11-02 |
Malaria conference begins in Nairobi, will highlight outlook for RTS,S experimental malaria vaccine |
None |
| 2009-11-02 |
Shortage of Tamiflu in liquid form contributes to dosage errors |
None |
| 2009-11-02 |
Sanofi Pasteur presents Menactra vaccine safety data at the IDSA |
None |
| 2009-11-02 |
Study of combination therapy versus monotherapy for pulmonary arterial hypertension |
None |
| 2009-11-02 |
FDA issues a Complete Response Letter for GTx' toremifene NDA |
None |
| 2009-11-02 |
Kinetic Concepts receives approval from MHLW in Japan to sell its V.A.C. Therapy System |
None |
| 2009-11-02 |
Canadian programs underscore evidence of PEGETRON's positive outcomes in treating HCV infection |
None |
| 2009-11-02 |
Sosei and ASKA Pharmaceuticals sign distribution agreement |
None |
| 2009-11-02 |
Unexpected consequences emerge in patients who are prescribed PPI medications for reflux diseases |
5 |
| 2009-11-02 |
ACTwatch data indicates low accessibility of artemisinin combination therapy |
None |
| 2009-11-02 |
India pharmaceuticals and healthcare report from Research and Markets |
None |
| 2009-11-02 |
New report on China's pharmaceuticals and healthcare industry |
None |
| 2009-11-02 |
Switching to new immunosuppressant drug may reduce skin cancer after kidney transplantation |
None |
| 2009-11-02 |
Amylin and Takeda to develop and commercialize pharmaceutical products for obesity |
None |
| 2009-11-02 |
Multicenter study finds AMD patients can benefit from cataract surgery |
None |